Clinical Trials Directory

Trials / Conditions / Detrusor Overactivity

Detrusor Overactivity

13 registered clinical trials studyying Detrusor Overactivity — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingPlatelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial
NCT07184307
Benha UniversityN/A
UnknownDeveloping a Simple Test to Diagnose Overactive Bladder
NCT05572918
Teesside University—
UnknownEffect of beta3-adrenoceptor Agonist on Patients With Overactive Bladder and as a Urinary Biomarker
NCT04693897
Chang Gung Memorial Hospital—
CompletedA Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of
NCT04543552
Seoul National University Hospital—
CompletedUNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation
NCT01850706
Northwell Health—
CompletedUSI and/or DO in Women With Cystocele Before and After Cystocele Repair
NCT04978714
National Taiwan University Hospital—
CompletedStudy of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
NCT01093534
Astellas Pharma IncPhase 4
TerminatedEfficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder
NCT01023269
MedtronicNeuroN/A
UnknownBotulinum A Toxin in Patients With Parkinson's Disease
NCT00822913
University Of PerugiaPhase 4
CompletedA Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Func
NCT00478881
BayerPhase 2
TerminatedRefractory Urge Incontinence and Botox Injections
NCT00373789
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 3
CompletedUltrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity
NCT01003457
Università degli Studi dell'Insubria—
CompletedA Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients
NCT00678795
Jazz PharmaceuticalsPhase 3